Completed NA INTERVENTIONAL 2-arm NCT02175888

The Optimization of Bioavailability From Iron Supplements: Study 1

The Optimization of Bioavailability From Iron Supplements: Examinations of Different Supplementation Regimens Including Hepcidin Profiles

Sponsor: Swiss Federal Institute of Technology

Conditions Anemia Iron Deficiency Iron Deficiency Anemia

Interventions Administrations of 60 mg iron in form of ferrous sulphate capsules on every second day for 28 days Daily administration of 60 mg iron in form of ferrous sulphate capsules for 14 consecutive days

Updated 5 times since 2017 Last updated: Nov 3, 2017 Started: Oct 31, 2015 Primary completion: Dec 31, 2015 Completion: Jan 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Anemia and Iron Deficiency and is currently completed. Swiss Federal Institute of Technology leads this study, which shows 5 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Oct 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Swiss Federal Institute of Technology

Data source: Swiss Federal Institute of Technology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zurich, Switzerland